Psilocybin and Mental Health-Don't Lose Control

被引：10

作者：

Barnby, Joseph M. ^{[1
]}

Mehta, Mitul A. ^{[1
]}

机构：

[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England

来源：

FRONTIERS IN PSYCHIATRY | 2018年 / 9卷

基金：

英国医学研究理事会;

关键词：

psychedelics; psilocybin; depression; clinical trials; methodology; LIFE-THREATENING CANCER; DEPRESSION; ANXIETY; TRIAL;

D O I：

10.3389/fpsyt.2018.00293

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页数：3

共 14 条

[1] Serotonin and brain function: a tale of two receptors [J].

Carhart-Harris, R. L. ;

Nutt, D. J. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (09) :1091-1120

[2] Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms [J].

Carhart-Harris, Robin L. ;

Roseman, Leor ;

Bolstridge, Mark ;

Demetriou, Lysia ;

Pannekoek, J. Nienke ;

Wall, Matthew B. ;

Tanner, Mark ;

Kaelen, Mendel ;

McGonigle, John ;

Murphy, Kevin ;

Leech, Robert ;

Curran, H. Valerie ;

Nutt, David J. .

SCIENTIFIC REPORTS, 2017, 7

[3] Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials [J].

Cortese, Samuele ;

Ferrin, Maite ;

Brandeis, Daniel ;

Holtmann, Martin ;

Aggensteiner, Pascal ;

Daley, David ;

Santosh, Paramala ;

Simonoff, Emily ;

Stevenson, Jim ;

Stringaris, Argyris ;

Sonuga-Barke, Edmund J. S. .

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (06) :444-455

[4] Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors [J].

Griffiths, Roland R. ;

Johnson, Matthew W. ;

Richards, William A. ;

Richards, Brian D. ;

Jesse, Robert ;

MacLean, Katherine A. ;

Barrett, Frederick S. ;

Cosimano, Mary P. ;

Klinedinst, Maggie A. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (01) :49-69

[5] Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial [J].

Griffiths, Roland R. ;

Johnson, Matthew W. ;

Carducci, Michael A. ;

Umbricht, Annie ;

Richards, William A. ;

Richards, Brian D. ;

Cosimano, Mary P. ;

Klinedinst, Margaret A. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (12) :1181-1197

[6] Human hallucinogen research: guidelines for safety [J].

Johnson, M. W. ;

Richards, W. A. ;

Griffiths, R. R. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (06) :603-620

[7] Psilocybin for depression and anxiety associated with life-threatening illnesses [J].

McCorvy, John D. ;

Olsen, Reid H. J. ;

Roth, Bryan L. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (12) :1209-1210

[8] Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future [J].

Nutt, David .

JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (12) :1163-1164

[9]

Palhano-Fontes F, 2018, BIORXIV, DOI [10.1101/103531, DOI 10.1101/103531]

[10]

Pecina M., JAMA Psychiatry, DOI DOI 10.1021/ACS.BIOCHEM.5B00087

← 1 2 →